PAUSE is a clinical trial testing the effectiveness of ustekinumab (STELARA®) followed by an investigational drug, abatacept, for the treatment of psoriasis. If you are between the ages of 18-65 and have been diagnosed with psoriasis for 6 months or longer, you may be eligible to participate.
PAUSE is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded). For more information, visit www.pausestudy.org.
30 июл 2015
